RT Journal Article
SR Electronic
T1 Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 923
OP 932
DO 10.3949/ccjm.83a.15116
VO 83
IS 12
A1 Ali Ataya
A1 Jessica Cope
A1 Abbas Shahmohammadi
A1 Hassan Alnuaimat
YR 2016
UL http://www.ccjm.org/content/83/12/923.abstract
AB Despite growing interest in thrombolytic agents to treat submassive pulmonary embolism, their role in this scenario remains controversial. Needed is a way to identify patients with this condition who are at risk of clinical deterioration and who would benefit from thrombolytic therapy. Here, we review the use of thrombolytic agents in submassive pulmonary embolism to help distinguish the risk and benefits of this therapy.